USE OF TRANSMEMBRANE ACTIVATOR, CALCIUM MODULATOR AND TACI-IMMUNOGLOBULIN FUSION PROTEINS FOR MANUFACTURE OF A MEDICAMENT FOR TREATING SJOGREN'S SYNDROEM

• 收藏
• 分享

专利权人:

ZYMOGENETICS INC.

发明人:

申请号：

IL21726511

公开号：

IL217265D0

申请日:

2011.12.29

申请国别(地区):

IL

年份:

2012

代理人:

摘要：

Molecules that interfere with the binding of a tumor necrosis factor receptor with its ligand, such as a soluble receptor, have proven usefulness in both basic research and as therapeutics. The present invention provides improved soluble transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) receptors.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/